An example of AbbVie’s efforts to better inform equitable, diverse and inclusive dermatological care in Canada and around the world, is the recently established, first-of-its-kind AbbVie Chair in Ethnodermatology at the Temerty Faculty of Medicine at University of Toronto. This Chair will address systemic inequities in clinical care, by providing advanced training to the next generation of clinicians to improve diagnosis, care and outcomes across ethnicities. This is important because accurate and timely diagnosis of skin conditions in people of colour is currently more difficult, as deeper skin tones does not reveal the true severity of conditions like psoriasis and eczema. Delayed diagnoses and treatment can result in more permanent scarring and discolouration than seen in people with less melanin.
Another meaningful initiative is our sponsorship of the AbbVie IBD Scholarship program run by Crohn’s and Colitis Canada, which helps students living with inflammatory bowel disease (IBD) fulfill their academic ambitions.
“As a patient-centric organization, AbbVie’s impact is significant,” says Sara Ghandeharian, manager of patient programs and evaluation at Crohn’s and Colitis Canada. “Since the AbbVie IBD Scholarship Program’s inception in 2012, it has helped fulfill the dreams of more than 130 students. Through AbbVie’s support, we also recently introduced a Wellness Series in response to a growing need to educate young people in managing all aspects of well-being, including mental health, and help strengthen knowledge on a broad range of IBD topics.”
AbbVie also supports Crohn’s and Colitis Canada’s Promoting Access and Care through Centres of Excellence (PACE) network, which brings together leading IBD centres from across Canada to improve health outcomes and access for those in rural areas, address gaps in care, and develop solutions that can create lasting change in the public health-care system.